CBIO
Crescent Biopharma
CBIO
CBIO
47 hedge funds and large institutions have $42.7M invested in Crescent Biopharma in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
21% less call options, than puts
Call options by funds: $450K | Put options by funds: $568K
34% less capital invested
Capital invested by funds: $64.9M → $42.7M (-$22.2M)
Holders
47
Holding in Top 10
–
Calls
$450K
Puts
$568K
Top Buyers
| 1 | +$351K | |
| 2 | +$266K | |
| 3 | +$210K | |
| 4 |
Two Sigma Investments
New York
|
+$161K |
| 5 |
EP
Eversept Partners
New York
|
+$144K |
Top Sellers
| 1 | -$799K | |
| 2 | -$490K | |
| 3 | -$119K | |
| 4 |
HF
HRT Financial
New York
|
-$112K |
| 5 |
D.E. Shaw & Co
New York
|
-$70.3K |